Danisco US Inc.

Danisco US Inc., Genencor Division

Melodie Estabrook

Brian E Jones

Marc Kolkman

Scott Douglas Power

Walter Weyler

Neelam S Amin

Chris Leeflang

David Aaron Estell

Clement K Choy

Katherine D Collier

Brian Frederick Schmidt

Casper Vroemen

Bryan P Fox

Claudine Chang

Gudrun Vogtentanz

James T Kellis, Jr

Karsten Matthias Kragh

Luis Gustavo Cascao-Pereira

Andrew Shaw

Lilia Maria Babe

Thomas P Graycar

Sina Pricelius

Zheyong Yu

Sandra W Ramer

Zhen Qian

Brian Sogaard Laursen

Casper Vroeman

Mansi Goyal

Victoria E Huang

Casper Willem Vroemen

Leo P M Van Marrewijk

Marc Koklman

Karsten Kraugh

Marc Kolkmam

Gudrun Vogentanz

Victoria Huang

James T Kellis

Karsten M Kragh

Leo PM Van Marrewijk

The present compositions and methods relate to an endo-&#x3b2;-mannanase cloned from, polynucleotides encoding the endo-&#x3b2;-mannanase, and methods of use thereof. Formulations containing the endo-&#x3b2;-mannanase are highly suitable for use as detergents.

[object Object]

The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

Modified variant Bowman Birk protease inhibitors

Described are variants (mutants) of a parent alpha-amylase having alpha-amylase activity and exhibiting altered properties relative to the parent alpha-amylase, and methods of use, thereof.

TS-23 alpha-amylase variants with altered properties

Compositions and methods relating to an alpha-amylase enzyme obtained fromWDG195 are described.

Variants ofsp. TS-23 strain alpha-amylases exhibit improved enzymatic performance, including increased thermostability, reduced calcium dependence, increased washing/cleaning performance, and baking ability. Compositions comprising these variants are useful in methods of starch processing, starch liquefaction, fermatation, starch saccharification, cleaning, laundrying, textile desizing, baking, and biofilm removal.

Disclosed herein are compositions comprising an alpha-amylase enzyme obtained fromsp. no. 195, and methods of using the enzyme to clean surfaces and textiles. Also disclosed are variants of the enzyme with different signal sequences.

Modified variant Bowman Birk Protease Inhibitors

TS23 alpha-amylase variants with altered properties

Variants ofsp. TS-23 strain alpha-amylases exhibit improved enzymatic performance, including increased themostability, reduced calcium dependence, increased washing/cleaning performance, and baking ability. Compositions comprising these variants are useful in methods of starch processing, starch liquefaction, fermatation, starch saccharification, cleaning, laundrying, textile desizing, baking, and biofilm removal.

Modified variant bowman birk protease inhibitors

The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses the compositions comprising the modified variant BBPIs, and the methods for making and using the compositions in personal care.

Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors

Growing community of inventors

Mountain View, CA, United States of America

Melodie Estabrook